{"url":"https://lda.gov/api/v1/filings/1d374959-7ae3-4071-963f-31e5e0e3ffaf/","filing_uuid":"1d374959-7ae3-4071-963f-31e5e0e3ffaf","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/1d374959-7ae3-4071-963f-31e5e0e3ffaf/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William Minor, Partner","dt_posted":"2026-04-20T10:06:10-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"500 8th Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":76855,"url":"https://lda.gov/api/v1/registrants/76855/","house_registrant_id":32113,"name":"DLA PIPER LLP (US)","description":"Law firm.","address_1":"500 8th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILLIAM MINOR","contact_telephone":"+1 202-799-4312","dt_updated":"2026-07-30T08:35:35.415773-04:00"},"client":{"id":67186,"url":"https://lda.gov/api/v1/clients/67186/","client_id":67186,"name":"BIOTECHNOLOGY INNOVATION ORGANIZATION","general_description":"Advocacy organization for the biotechnology industry.","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-04-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to reimbursement under Medicare Part B and Part D. Medicare and Medicaid payment and coverage issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147290,"prefix":null,"prefix_display":null,"first_name":"KARINA","nickname":null,"middle_name":null,"last_name":"LYNCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149001,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"BURR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139175,"prefix":"mr","prefix_display":"MR.","first_name":"JAMIE","nickname":null,"middle_name":"ALEXEI","last_name":"GREGORIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142802,"prefix":null,"prefix_display":null,"first_name":"MARGARET","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149501,"prefix":null,"prefix_display":null,"first_name":"VINCENT","nickname":null,"middle_name":null,"last_name":"SARUBBI","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":145585,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"PORTMAN","suffix":null,"suffix_display":null},"covered_position":"Deputy Health Policy Director, Committee on Senate Health, Education, Labor and Pensions; Health Policy Assistant, Sen. Richard Burr; Intern, Sen. Robert Portman","new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"340B drug discount program. General issues related to health care. H.R. 946, ORPHAN Cures Act. Issues related to FDA drug review, including PDUFA.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147290,"prefix":null,"prefix_display":null,"first_name":"KARINA","nickname":null,"middle_name":null,"last_name":"LYNCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149001,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"BURR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139175,"prefix":"mr","prefix_display":"MR.","first_name":"JAMIE","nickname":null,"middle_name":"ALEXEI","last_name":"GREGORIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142802,"prefix":null,"prefix_display":null,"first_name":"MARGARET","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149501,"prefix":null,"prefix_display":null,"first_name":"VINCENT","nickname":null,"middle_name":null,"last_name":"SARUBBI","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":145585,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"PORTMAN","suffix":null,"suffix_display":null},"covered_position":"Deputy Health Policy Director, Committee on Senate Health, Education, Labor and Pensions; Health Policy Assistant, Sen. Richard Burr; Intern, Sen. Robert Portman","new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149001,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"BURR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147290,"prefix":null,"prefix_display":null,"first_name":"KARINA","nickname":null,"middle_name":null,"last_name":"LYNCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139175,"prefix":"mr","prefix_display":"MR.","first_name":"JAMIE","nickname":null,"middle_name":"ALEXEI","last_name":"GREGORIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142802,"prefix":null,"prefix_display":null,"first_name":"MARGARET","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149501,"prefix":null,"prefix_display":null,"first_name":"VINCENT","nickname":null,"middle_name":null,"last_name":"SARUBBI","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":145585,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"PORTMAN","suffix":null,"suffix_display":null},"covered_position":"Deputy Health Policy Director, Committee on Senate Health, Education, Labor and Pensions; Health Policy Assistant, Sen. Richard Burr; Intern, Sen. Robert Portman","new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147290,"prefix":null,"prefix_display":null,"first_name":"KARINA","nickname":null,"middle_name":null,"last_name":"LYNCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149001,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":null,"last_name":"BURR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139175,"prefix":"mr","prefix_display":"MR.","first_name":"JAMIE","nickname":null,"middle_name":"ALEXEI","last_name":"GREGORIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142802,"prefix":null,"prefix_display":null,"first_name":"MARGARET","nickname":null,"middle_name":null,"last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149501,"prefix":null,"prefix_display":null,"first_name":"VINCENT","nickname":null,"middle_name":null,"last_name":"SARUBBI","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":145585,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"PORTMAN","suffix":null,"suffix_display":null},"covered_position":"Deputy Health Policy Director, Committee on Senate Health, Education, Labor and Pensions; Health Policy Assistant, Sen. Richard Burr; Intern, Sen. Robert Portman","new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}